Position in GILD
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$249,900
-$54,902 QoQ
Shares Held
1,978
-9.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,789
of 2,266 holders
Holding Since
Mar 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTH STAR ASSET MANAGEMENT INC holds $29,508,507 across 9 Drug Manufacturers - General names. GILD ranks #9 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,325 | $13,583,545 | |
| 2 | JNJ |
Johnson & Johnson
|
28,155 | $7,150,524 | |
| 3 | AMGN |
Amgen Inc
|
10,471 | $3,791,758 | |
| 4 | NVO |
Novo Nordisk A S
|
40,676 | $1,950,007 | |
| 5 | PFE |
Pfizer Inc
|
40,700 | $980,056 | |
| 6 | NVS |
Novartis AG
|
6,158 | $965,081 | |
| 7 | GSK |
GSK plc
|
8,108 | $425,021 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
7,161 | $412,615 |
All Filings in GILD
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $249,900 | 1,978 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $304,802 | 2,187 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $265,977 | 2,167 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $241,203 | 2,173 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $240,809 | 2,172 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $243,372 | 2,172 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $200,627 | 2,172 | Shares | Sole | 2025-02-19 | |
| 2021-09-30 | $232,041 | 3,322 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $246,518 | 3,580 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $281,463 | 4,355 | Shares | Sole | 2021-04-29 | |
| No filing history on record for this holder in this stock. | ||||||